Announced
Financials
Tags
Acquisition
Pending
Australia
devices
biotech
pharma
life sciences
Biotechnology
Private
Single Bidder
Friendly
Majority
Synopsis
China Grand Pharmaceutical and CDH Genetech Limited, two healthcare companies, agreed to acquire Sirtex Medical, a global life sciences and life technology company, which develop and provide effective cancer treatment products, for $1.3bn. “CDH recognizes Australia’s leadership in medical research and its world-class regulatory system. In particular, CDH sees significant potential to introduce Sirtex’s liver cancer treatment product into China,” CHD Genetech.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.